Picture of Glaukos logo

GKOS Glaukos Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapFalling Star

Annual income statement for Glaukos, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue225294283315383
Cost of Revenue
Gross Profit133227214239289
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses349327365443506
Operating Profit-124-32.9-82.3-129-122
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-132-49.3-98.4-134-146
Provision for Income Taxes
Net Income After Taxes-120-49.6-99.2-135-146
Net Income Before Extraordinary Items
Net Income-120-49.6-99.2-135-146
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-120-49.6-99.2-135-146
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-2.63-1.25-2.29-2.68-2.5